Showing results (321-330 of 630) with videos related to
Sort By:
Pageof 63
Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 21, 2025
Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, in Patients with Asthma or COPD, Evaluated Using Functional Respiratory ImagingNavid Monshi Tousi, Romina Osello, Debora Santoro, et al.Oxford Medical Case Reports|July 29, 2022
Cardiac electrical instability in Erdheim-Chester disease: a case reportAndrea Urbani, Filippo Pensotti, Diego Castini, et al.Human Gene Therapy|December 1, 2001
Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD)H Rasmussen, K W Chu, P Campochiaro, et al.Ophthalmology|August 25, 2009
Monitoring ocular drug therapy by analysis of aqueous samplesPeter A Campochiaro, David F Choy, Diana V Do, et al.Frontiers in Oncology|February 13, 2023
Case report: Successful use of mepolizumab for immune checkpoint inhibitors-induced hypereosinophilic syndrome in two patients with solid malignanciesChiara Lazzari, Mona Rita Yacoub, Corrado Campochiaro, et al.Seminars in Arthritis and Rheumatism|March 27, 2024
Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients' handsAslihan Avanoglu-Guler, Corrado Campochiaro, Giacomo De Luca, et al.Expert Review of Clinical Immunology|February 21, 2026
Drug development in systemic sclerosis: novel therapeutics to watchVeronica Batani, Jelena Colic, Cristina Scaletti, et al.Ophthalmology|July 1, 2011
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyPeter A Campochiaro, David M Brown, Carl C Awh, et al.The American Journal of Pathology|November 12, 1998
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine modelT Tobe, S Ortega, J D Luna, et al.Journal of Cellular Physiology|February 12, 2014
Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGFJikui Shen, David F Choy, Tsunehiko Yoshida, et al.Pageof 63